Cargando…
Concise Review: Is Cardiac Cell Therapy Dead? Embarrassing Trial Outcomes and New Directions for the Future
Stem cell therapy is a promising strategy for tissue regeneration. The therapeutic benefits of cell therapy are mediated by both direct and indirect mechanisms. However, the application of stem cell therapy in the clinic is hampered by several limitations. This concise review provides a brief introd...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5866934/ https://www.ncbi.nlm.nih.gov/pubmed/29468830 http://dx.doi.org/10.1002/sctm.17-0196 |
_version_ | 1783308898401255424 |
---|---|
author | Tang, Jun‐Nan Cores, Jhon Huang, Ke Cui, Xiao‐Lin Luo, Lan Zhang, Jin‐Ying Li, Tao‐Sheng Qian, Li Cheng, Ke |
author_facet | Tang, Jun‐Nan Cores, Jhon Huang, Ke Cui, Xiao‐Lin Luo, Lan Zhang, Jin‐Ying Li, Tao‐Sheng Qian, Li Cheng, Ke |
author_sort | Tang, Jun‐Nan |
collection | PubMed |
description | Stem cell therapy is a promising strategy for tissue regeneration. The therapeutic benefits of cell therapy are mediated by both direct and indirect mechanisms. However, the application of stem cell therapy in the clinic is hampered by several limitations. This concise review provides a brief introduction into stem cell therapies for ischemic heart disease. It summarizes cell‐based and cell‐free paradigms, their limitations, and the benefits of using them to target disease. stem cells translational medicine 2018;7:354–359 |
format | Online Article Text |
id | pubmed-5866934 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-58669342018-03-28 Concise Review: Is Cardiac Cell Therapy Dead? Embarrassing Trial Outcomes and New Directions for the Future Tang, Jun‐Nan Cores, Jhon Huang, Ke Cui, Xiao‐Lin Luo, Lan Zhang, Jin‐Ying Li, Tao‐Sheng Qian, Li Cheng, Ke Stem Cells Transl Med Translational Research Articles and Reviews Stem cell therapy is a promising strategy for tissue regeneration. The therapeutic benefits of cell therapy are mediated by both direct and indirect mechanisms. However, the application of stem cell therapy in the clinic is hampered by several limitations. This concise review provides a brief introduction into stem cell therapies for ischemic heart disease. It summarizes cell‐based and cell‐free paradigms, their limitations, and the benefits of using them to target disease. stem cells translational medicine 2018;7:354–359 John Wiley and Sons Inc. 2018-02-22 /pmc/articles/PMC5866934/ /pubmed/29468830 http://dx.doi.org/10.1002/sctm.17-0196 Text en © 2018 The Authors Stem Cells Translational Medicine published by Wiley Periodicals, Inc. on behalf of AlphaMed Press This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial‐NoDerivs (http://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | Translational Research Articles and Reviews Tang, Jun‐Nan Cores, Jhon Huang, Ke Cui, Xiao‐Lin Luo, Lan Zhang, Jin‐Ying Li, Tao‐Sheng Qian, Li Cheng, Ke Concise Review: Is Cardiac Cell Therapy Dead? Embarrassing Trial Outcomes and New Directions for the Future |
title | Concise Review: Is Cardiac Cell Therapy Dead? Embarrassing Trial Outcomes and New Directions for the Future |
title_full | Concise Review: Is Cardiac Cell Therapy Dead? Embarrassing Trial Outcomes and New Directions for the Future |
title_fullStr | Concise Review: Is Cardiac Cell Therapy Dead? Embarrassing Trial Outcomes and New Directions for the Future |
title_full_unstemmed | Concise Review: Is Cardiac Cell Therapy Dead? Embarrassing Trial Outcomes and New Directions for the Future |
title_short | Concise Review: Is Cardiac Cell Therapy Dead? Embarrassing Trial Outcomes and New Directions for the Future |
title_sort | concise review: is cardiac cell therapy dead? embarrassing trial outcomes and new directions for the future |
topic | Translational Research Articles and Reviews |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5866934/ https://www.ncbi.nlm.nih.gov/pubmed/29468830 http://dx.doi.org/10.1002/sctm.17-0196 |
work_keys_str_mv | AT tangjunnan concisereviewiscardiaccelltherapydeadembarrassingtrialoutcomesandnewdirectionsforthefuture AT coresjhon concisereviewiscardiaccelltherapydeadembarrassingtrialoutcomesandnewdirectionsforthefuture AT huangke concisereviewiscardiaccelltherapydeadembarrassingtrialoutcomesandnewdirectionsforthefuture AT cuixiaolin concisereviewiscardiaccelltherapydeadembarrassingtrialoutcomesandnewdirectionsforthefuture AT luolan concisereviewiscardiaccelltherapydeadembarrassingtrialoutcomesandnewdirectionsforthefuture AT zhangjinying concisereviewiscardiaccelltherapydeadembarrassingtrialoutcomesandnewdirectionsforthefuture AT litaosheng concisereviewiscardiaccelltherapydeadembarrassingtrialoutcomesandnewdirectionsforthefuture AT qianli concisereviewiscardiaccelltherapydeadembarrassingtrialoutcomesandnewdirectionsforthefuture AT chengke concisereviewiscardiaccelltherapydeadembarrassingtrialoutcomesandnewdirectionsforthefuture |